WT1 and myelodysplastic syndrome: Furthermore, our data indicated that PB WT1-mRNA expression status significantly correlated with prognosis of MDS patients with those patients showing WT1-mRNA overexpression having a higher risk for disease progression and AML transformation and accordingly shorter progression-free, leukemia-free and overall survival.